Vis enkel innførsel

dc.contributor.authorSchulze, Daniel Gregor
dc.contributor.authorNilsen, Kristian Bernhard
dc.contributor.authorKillingmo, Rikke Munk
dc.contributor.authorZwart, John Anker
dc.contributor.authorGrotle, Margreth
dc.date.accessioned2022-01-20T12:17:30Z
dc.date.available2022-01-20T12:17:30Z
dc.date.created2021-08-23T13:37:24Z
dc.date.issued2021-07-27
dc.identifier.citationFrontiers in Neurology. 2021, 12 1-10.en_US
dc.identifier.issn1664-2295
dc.identifier.urihttps://hdl.handle.net/11250/2838472
dc.description.abstractBackground: Self-reported measures are often used in research and clinical practice to diagnose carpal tunnel syndrome (CTS) and guide therapeutic choices. We aimed to assess the clinical utility of the Norwegian versions of two self-reported outcome measures for symptom severity assessment, the 6-item CTS (CTS-6), and Boston-CTS (BCTQ), and of one diagnostic measure, the hand-diagram, by evaluating measurement properties including discriminative ability for severity assessment (CTS-6, BCTQ), and diagnosis of CTS (hand-diagram). Methods: We performed forward and backward translation and cultural adaptation of the Norwegian CTS-6 and BCTQ. Following COSMIN guidelines, we investigated internal consistency, reliability, construct validity, and discriminative ability for distinguishing between severity levels of CTS in patients with confirmed CTS for the CTS-6 and BCTQ and reliability and discriminative ability for diagnosing CTS for the hand-diagram. Results: Two hundred and fifty-one patients referred for diagnostic work-up for CTS with nerve conduction studies (NCS) participated. The CTS-6 and BCTQ had acceptable internal consistency (Crohnbach’s α = 0.82 and 0.86, respectively), reliability (ICC = 0.86 and 0.90; SEM = 0.24 and 0.20; SDC95% = 0.68 and 0.55, respectively), construct validity (all eight pre-defined hypotheses confirmed) and discriminative ability to distinguish between severity levels of CTS [Area under the curve (AUC) = 0.75, 95% CI 0.64–0.85]. The hand-diagram had acceptable reliability (Cohen’s kappa = 0.69) and discriminative ability to diagnose CTS (sensitivity = 0.72, specificity = 0.90). Conclusion: Our findings support the clinical utility of the CTS-6 and BCTQ for symptom severity assessment and of the hand-diagram for diagnostic screening.en_US
dc.language.isoengen_US
dc.publisherFrontiers Mediaen_US
dc.relation.ispartofseriesFrontiers in Neurology;July 2021 | Volume 12 | Article 683807
dc.rightsNavngivelse 4.0 Internasjonal*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/deed.no*
dc.subjectClinical utilitiesen_US
dc.subjectNorwegian languageen_US
dc.subject6-item carpal tunnel syndromeen_US
dc.subjectHand-diagramsen_US
dc.subjectBoston carpal tunnel syndrome questionnairesen_US
dc.subjectCOSMIN checklisten_US
dc.titleClinical Utility of the 6-Item CTS, Boston-CTS, and Hand-Diagram for Carpal Tunnel Syndromeen_US
dc.typePeer revieweden_US
dc.typeJournal articleen_US
dc.description.versionpublishedVersionen_US
dc.rights.holder© 2021 Schulze, Nilsen, Killingmo, Zwart and Grotle.en_US
dc.source.articlenumber683807en_US
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode1
dc.identifier.doihttps://doi.org/10.3389/fneur.2021.683807
dc.identifier.cristin1928045
dc.source.journalFrontiers in Neurologyen_US
dc.source.volume12en_US
dc.source.pagenumber1-10en_US


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel

Navngivelse 4.0 Internasjonal
Med mindre annet er angitt, så er denne innførselen lisensiert som Navngivelse 4.0 Internasjonal